How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

As language models (LMs) improve at tasks like image generation, trivia questions, and simple math, you might think that ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Systematic evolution of ligands by exponential enrichment (SELEX) is a method used to select and characterize aptamers. These aptamers are powerful molecular recognition agents, akin to antibodies, ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. The market approach is a method for determining the value of an ...

Tommaso Grossi and colleagues propose NeuberNet, a multi-task manifold decoder that maps low-fidelity elastic displacement fields to high-resolution stress-strain in regions with sharp notches. This ...

Analyzing stochastic cell-to-cell variability can potentially reveal causal interactions in gene regulatory networks.

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...

Getting good at LeetCode Java can feel like a puzzle sometimes, right? You see all these problems, and you’re not sure where ...